Fig. 1
73 year old man with imaging for metastatic cutaneous squamous cell carcinoma to the lung post 12 months of cemiplimab 350 mg/3-weekly. a demonstrating a CMR to treatment and (b) demonstrating ongoing RECIST1.1 PR with measurable disease on CT